OKLAHOMA · CONTRACT FOR CARE EVIDENCE
Comprehensive Spine and Pain / Western Oklahoma Pain Specialists — 2026 patient agreement
This record examines the practice’s publicly hosted 27-page 2026 New Patient Paperwork and separates Oklahoma requirements from practice-selected conditions. Seeds of Vice also received an independent patient-origin copy of the same 2026 packet. Patient identifiers and medical information are not reproduced here.
What Oklahoma actually requires
Oklahoma requires patient-provider opioid agreements in defined circumstances. The statute describes subjects an agreement may contain—including refill and outside-prescriber restrictions, treatment modalities, specimen screening, pill counts, and termination consequences. Those statutory categories do not make every clinic’s particular implementation a uniform statewide rule.
Current Oklahoma law also states that opioid treatment should be effective and individualized and does not require an administrative or codified dose limit more restrictive than FDA approval.
Clause-by-clause findings
| Practice requirement | Classification | Why it matters |
|---|---|---|
| Signature/initials before pain medication. The packet says the patient must initial each item and sign the agreement before receiving pain medication. | Mixed: statutory agreement requirement + practice-wide implementation. | Oklahoma requires an executed agreement in defined circumstances; the packet presents its entire agreement as a prerequisite to pain medication. Whether every patient presented the form falls within a statutory trigger is a separate factual question. |
| Compliance with all aspects of the treatment plan. | Practice-selected / broader than a uniform statewide requirement. | Oklahoma contemplates treatment plans and other modalities; it does not establish a blanket statewide requirement that every opioid patient accept every modality selected by an office. |
| One-practice prescribing. Other prescriptions, including from health, dental, or emergency departments, require practice authorization. | Authorized/contemplated; exact breadth is practice-selected. | Oklahoma agreements may restrict outside opioid prescriptions and Medical Board guidance favors one physician/one pharmacy when possible. The clinic’s extension to other settings is its implementation. |
| Morphine-equivalent dose limitation attributed to the 2016 CDC Guideline and state law. | Source conflict / legal review. | The 2016 CDC guideline used a 90-MME caution threshold, not an absolute statutory ceiling. CDC replaced that guideline in 2022 and expressly warns against rigid numeric standards. Oklahoma currently uses >100 MME as an agreement/documentation trigger, not a universal ceiling. |
| Lost/stolen medication: no early refill and possible taper/discontinuation. | Practice-selected condition. | The statewide agreement framework permits refill conditions but does not itself establish this exact consequence for every patient. |
| Random pill counts with a 24-hour appearance deadline. | Authorized monitoring; exact deadline/consequence practice-selected. | Oklahoma expressly contemplates pill counts. The 24-hour deadline and dismissal/taper consequences are clinic terms. |
| Random urine, oral, blood, or hair screening with taper/discontinuation or dismissal consequences. | Authorized monitoring; modalities and consequences practice-selected. | Specimen screening is contemplated by Oklahoma law. For SoonerCare, oral/hair testing and routine/scheduled testing are specifically non-compensable; that payer rule is not a universal prohibition on private-practice testing. |
| Failure to follow treatment plans—including injections, physical therapy, and referrals—may lead to dismissal. | Practice-selected condition; financial-dependency review. | The practice separately discloses ownership interests in multiple health entities and says patients may use alternative providers/facilities without being treated differently. Current evidence therefore does not establish that a patient must buy an affiliated service. Whether particular services are required, where they may be obtained, and who bills for them requires transaction-level evidence. |
| Routine Creyos testing as a condition of receiving pain medication, with an eyesight exception. | Practice-selected service condition; high-value review item. | No Oklahoma statute or statewide rule identified in this review requires routine Creyos cognitive testing as a condition of opioid treatment. The practice’s public 2026 form makes it a condition. Billing, frequency, and financial relationships remain to be established. |
| Provider may terminate the agreement and medications if the provider has reason to believe the patient violated the agreement or treatment plan. | Termination process contemplated; exact standard practice-selected. | Oklahoma agreements are expected to delineate termination consequences. The clinic’s “reason to believe” standard and medication consequences are its implementation and may require legal/clinical review in an individual case. |
| Negative social-media speech can be grounds for termination. | Practice-selected; federal consumer-law review required. | The federal Consumer Review Fairness Act generally voids standardized consumer-contract terms that prohibit or restrict honest reviews or impose a penalty for them. The clinic’s clause separately mentions slander and “talking negatively”; application of federal law to this specific clause and healthcare relationship is flagged for legal review rather than declared here. |
| No appointments unless balances are paid or a payment plan is established. | Practice financial policy. | The opioid agreement also says regular appointments are used for medication renewals/refills, creating a documented relationship between appointment access and continuing medication management. The record does not infer illegality from that fact. |
| Urine testing described as medically necessary, with no exceptions to standard policy; patient bears cost when insurance does not pay. | Practice-selected financial/testing condition; ownership review. | The practice’s ownership disclosure states that Brian Blick, MD has an ownership interest in Western Oklahoma Pain Specialists Lab. Current evidence does not yet establish whether the mandatory urine testing in this packet is performed or billed by that laboratory. That link must be proved before any stronger conclusion is published. |
| Concurrent benzodiazepine or benzodiazepine-like medication leads to opioid taper/discontinuation if it cannot be stopped; the policy calls this nonnegotiable. | Broader than current statewide/federal guidance. | Current CDC guidance calls for particular caution and individualized benefit-risk assessment rather than an absolute prohibition. Oklahoma’s statute treats concurrent opioid/benzodiazepine therapy as a trigger for an agreement, not a statewide ban. |
Ownership and patient-choice evidence
The practice’s own disclosure reports ownership interests involving Oklahoma Center for Orthopedic & Multi-Specialty Surgery, Western Oklahoma Pain Specialists Lab, and OneCore Health. The same disclosure states that a patient is under no obligation to receive services at a recommended facility, may use another provider or facility, and will not be treated differently for doing so.
Evidence boundary: those disclosures establish ownership and a stated right to choose. They do not establish where any particular patient’s testing, procedure, therapy, or other service was billed. Seeds of Vice will not characterize an arrangement as an unlawful tie, kickback, or compelled purchase without evidence proving the relevant transaction and legal elements.
Primary sources and practice response
- Comprehensive Spine and Pain — 2026 New Patient Paperwork
- Current practice website
- Oklahoma State Department of Health — opioid prescribing resources
- CDC 2022 Clinical Practice Guideline
- FTC — Consumer Review Fairness Act guidance
Practice-verification status: current 2026 document publicly supplied by the practice website; no separate Seeds of Vice verification response has yet been requested or received.
Practice representatives may verify or correct this record →